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Abstract 
 
Objectives: To update previous systematic reviews of 12-month prevalence of CAM use by general populations; to 
explore trends in CAM use by national populations; to develop and apply a brief tool for assessing methodological 
quality of published CAM-use prevalence surveys. 
 
Design: Nine databases were searched for published studies from 1998 onwards. Studies prior to 1998 were identified 
from two previous systematic reviews. A six-item literature-based tool was devised to assess robustness and 
interpretability of CAM-use estimates. 
 
Results: Fifty-one reports from 49 surveys conducted in 15 countries met the inclusion criteria. We extracted 32 
estimates of 12-month prevalence of use of any CAM (range 9.8% to 76%) and 33 estimates of 12-month prevalence 
of visits to CAM practitioners (range 1.8% to 48.7%). Quality of methodological reporting was variable; 30/51 survey 
reports (59%) met four or more of six quality criteria. Estimates of 12-month prevalence of any CAM use (excluding 
prayer) from surveys using consistent measurement methods showed remarkable stability in Australia (49%, 52%, 
52%; 1993, 2000, 2004) and USA (36%, 38%; 2002, 2007). 
 
Conclusions: There was evidence of substantial CAM use in the 15 countries surveyed. Where national trends were 
discernable due to consistent measurement, there was no evidence to suggest a change in 12-month prevalence of 
CAM use since the previous systematic reviews were published in 2000. Periodic surveys are important to monitor 
population-level CAM use. Use of government-sponsored health surveys may enhance robustness of population-
based prevalence estimates. Comparisons across countries could be improved by standardising approaches to data 
collection. 
 
Review Criteria 
x Nine databases were searched from 1998 onwards; prior studies were identified from two previous systematic 
reviews. 
x Studies were included if they reported prevalence of CAM use over 12-months in a representative sample of the 
general population. Studies were excluded if restricted to a single CAM therapy, or not written in English. 
x A six-item tool to assess quality of published CAM-use prevalence surveys was devised and applied. 
 
Message for the Clinic 
x The review included 51 reports from 49 surveys in 15 countries: estimates of 12-month prevalence of any CAM 
use ranged from 9.8% to 76%; and 1.8% to 48.7% for visits to CAM practitioners. 
x There was no evidence of a change in CAM use since previous reviews were published in 2000. 
x Periodic surveys with consistent measurement methods are needed to determine trends in CAM use by national 
populations. 
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Introduction 
 
It has been more than ten years since two systematic reviews of surveys of complementary and alternative medicine 
(CAM) use by the general public were published [1, 2]. The reviews concluded, independently, that despite the 
methodological limitations of the surveys included, CAM was used by substantial proportions of the general 
populations of a number of countries. One source [3] suggested that CAM use increased significantly in the USA 
between 1990 and 1997. A further review is timely to examine more recent trends and their implications for healthcare 
systems and policy as well as for consumers of CAM. 
 
The use of all types of medicine is influenced by economic and socio-cultural factors. In economically disadvantaged 
societies where access to biomedical services is poor, there is evidence of a pervasive reliance on traditional healers, 
even for serious disease [4]. In affluent countries, where biomedical services are more accessible, a substantial 
amount of CAM is used for illness prevention and health promotion purposes [3]. There is also evidence that CAM is 
frequently used as an adjunct to biomedical treatment by patients with serious disease such as cancers [5, 6] and to 
self-manage long-term health complaints like low back pain [7]. However, the socio-cultural factors influencing CAM 
use in affluent societies are still not well understood. Studies have persistently shown that CAM users are more likely 
to be female, better educated, middle-aged, and report poorer health status than non users [6, 8-12]. CAM use 
appears to be driven more by congruence with values and beliefs than by dissatisfaction with biomedicine [10] but 
motivation to use CAM is further complicated by costs and benefits as experienced by consumers. 
 
While the true rate of CAM use can be expected to differ between countries due to economic, social and cultural 
factors, the prevalence rates estimated by surveys are also affected by methodological factors. Some of these have 
been identified [2] with the recommendation that surveys justify the types of CAM surveyed; use pretested data 
collection methods; distinguish between consultations with CAM practitioners and over-the-counter products; seek 
reports of usage for each of the practitioner therapies and products identified; and specify the period over which CAM 
use is estimated (most surveys choose a 12 month retrospective period). Others have also recommended a more 
standardised method of collecting data to improve the comparability of CAM use estimates [13]. 
 
The two previous reviews of CAM prevalence [1, 2] each included 12 surveys for review with seven1 common to both 
studies due to differences in search methods and selection criteria. The current study has drawn on these two earlier 
reviews to develop more rigorous criteria for searching and selection and aims to i) systematically review all surveys of 
CAM use by the general public, ii) identify trends in CAM use by national populations, iii) develop a brief tool for 
assessing methodological quality and apply it to each survey. 
 
Methods 
 
Search strategy 
The systematic review followed the recommendations in the PRISMA statement [16]. The following databases were 
searched in February 2011: MEDLINE, Medline in Process, EMBASE, Cochrane Database of Systematic Reviews, 
Cochrane CENTRAL Register of Controlled Trials, HTA database, Science Citation Index, AMED, and PsycINFO. The 
search strategy combined terms for: i) complementary and alternative medicines, ii) prevalence, surveys or patterns of 
                                               
1
 Data for Thomas 1993 [14] and Vickers 1994 [15] are from the same survey source. 
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use, and iii) population-level or national-level data. The full search strategy is provided in Appendix 1. The search was 
restricted to studies published from 1998 onwards. Studies published prior to 1998 were identified from two previous 
systematic reviews of CAM prevalence [1, 2]. Bibliographies of included papers were checked for further relevant 
studies. 
 
Inclusion and exclusion criteria  
Studies were included if they reported prevalence of CAM use over a 12-month retrospective period within a 
representative general population sample of a nation or a defined geographical area. Surveys of clearly-defined age 
groups (such as adults or children) were also included. Included studies used survey methods such as structured 
interviews or self-complete questionnaires. Studies were excluded if they were restricted to a single therapy (rather 
than CAM use overall), did not report 12-month prevalence, or were not written in English. Studies were also excluded 
if they were not based on representative samples of the general population; for example, surveys of sub-populations 
with specific clinical conditions or socio-demographic characteristics (other than age). 
 
Study selection and data extraction 
Study titles retrieved by the search were assessed for inclusion by one reviewer and a sample of excluded titles was 
checked by a second reviewer: no instances of discrepancy were found. Potentially relevant abstracts and full texts 
were assessed by two reviewers and any discrepancies resolved through discussion. Data were extracted by one 
reviewer and checked by a second. 
 
Quality assessment 
There is no agreed set of criteria for assessing quality of health-related surveys, although various publications have 
explored issues relating to the critical review of questionnaire-based surveys in health research [17-22], and previous 
studies of CAM-use prevalence have commented on these issues [2, 14, 23, 24]. 
 
For the purposes of this review, we derived a short, literature-based quality assessment tool comprising important and 
assessable criteria of methodological quality, and applied this to each of the eligible papers identified. Our rationale for 
selecting quality criteria related to the need to assess the robustness and interpretability of published CAM-use 
estimates. Our quality criteria reflect a combination of aspects of study design, study conduct and the reporting of 
results (Box 1). 
 
Rationale for quality criteria 
Study design 
As with all surveys of prevalence, the estimates produced are the direct product of the questions asked; slight 
changes in the form of questions will have the potential to affect the resulting estimates. This is particularly important 
in surveys of CAM where multiple, and sometimes culturally specific understandings exist in relation to the practice 
and to the constituent therapies [2, 23]. CAM prevalence surveys have employed one of two data collection methods; 
either a list of named therapies is presented, or more exploratory, open question(s) are used to elicit CAM use. Our 
first criterion required papers to reproduce the CAM survey question(s) verbatim or describe the CAM question in the 
text (e.g. ³ZHDVNHGDERXW«´). For closed questions, we required a list of the pre-specified therapies (and exclusions) 
presented to survey respondents (described clearly enough for the individual therapies to be counted reliably). Where 
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open question(s) were used to collect CAM-use data, we sought evidence of the content and number of open 
questions employed. 
 
Since the measurement process for CAM-use is complex and variable, the validity of the survey instrument is 
strengthened if it has been tested in a pilot study for ease of completion and comprehensibility [2, 14, 18]. Evidence of 
such piloting formed our second criterion. Explicit mention of a pilot was sought for all studies, but routine, 
government-sponsored surveys were assumed to have undergone a piloting phase as this is standard practice and 
frequently described in separate, methodological papers or reports. 
 
Adequate sample size enhances the robustness of the estimates produced and, if something is known about expected 
prevalence prior to the survey, a sample size calculation can be performed to ensure adequate numbers for each item 
of importance to be measured [18, 20-22].  Surveys of CAM use that are part of wider-scope studies of health 
behaviour tend to have large samples, but may not perform sample size calculations in relation to items measuring 
CAM use. Our third criterion was met if studies reported a sample of at least 1,000, and/or if they reported a sample 
size calculation specific to CAM use. 
 
Data collection 
3UHYLRXVSDSHUVKDYHFLWHGµJRRG¶UHVSRQVHUDWHVIRUVXUYH\VDVEHWZHHQ-DQGµDFFHSWDEOH¶UHVSRQVHUDWHVIRU
postal surveys between 50% and 60% [18, 20-22, 24]. Our fourth criterion was deemed to have been met if studies 
reported a response rate of at least 60% (we accepted adjusted or unadjusted response rates and report these in 
Table 1). 
 
Analysis  
Our fifth quality criterion was deemed to have been met if appropriate correction for non-response bias was used; for 
example, weighting the responses to the known characteristics of the original sample population [18, 20-22]. 
 
Reporting of estimates 
Finally, 95% confidence intervals (CIs) provide an estimate of the range in which the true prevalence value is 
expected to lie [18, 20-22, 25] DQGWKHUHIRUHSURYLGHPRUHLQIRUPDWLRQZKLOVWUHGXFLQJWKHOLNHOLKRRGRIµIDOVH¶SUHFLVLRQ
being attributed to the estimates. Our sixth and final quality criterion was therefore met when studies reported 95% 
CIs, or standard errors (SEs) from which the CI can be calculated, for the main CAM-use prevalence estimates. 
 
Insert Box 1 about here 
 
Results 
 
Number of surveys included 
The search identified 2312 unique citations, as shown in Figure 1. Of these, 2208 were excluded at the title and 
abstract stage, while the full texts of 104 references were examined. Forty-seven references were included in the 
review; three references [11, 26, 27] together contained reports from seven independent surveys, while four 
references [24, 28-30] relating to two surveys gave separate reports for adults and children. In total, the 47 references 
reviewed contained 51 reports from 49 independent surveys. From these reports, we extracted 32 separate estimates 
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of the 12-month prevalence of the use of any CAM and 33 estimates of the 12-month prevalence of visits to CAM 
practitioners. 
 
Insert Figure 1 about here 
 
Quality assessment 
Table 1 identifies the 49 surveys ordered by the number of surveys per country, the country of origin, and the year of 
data collection. Each of the 51 survey reports (two surveys giving separate reports for adults and children) is assessed 
using the six quality criteria developed for this review. 
 
Based on the information reported, we assessed all surveys reviewed with regards to our six quality criteria (see Table 
2). The proportion of all survey reports achieving each of our criteria ranged from 43% to 84%. The criteria least likely 
to be met were (5) data weighting to reduce non-response bias, and (6) reporting CI or SE for key prevalence 
estimates. Fifty-nine percent of all survey reports met four or more of our quality criteria. Although proportionately 
more reports from government±sponsored surveys achieved four or more of the quality criteria compared to other 
survey reports, and there was a trend towards more of these reports meeting each individual criterion, the only 
marked difference observed was for the piloting criterion, where we made the assumption that all government-
sponsored surveys were piloted. We found no evidence of an association between date of publication and quality. 
 
Insert Table 2 about here 
 
Prevalence of CAM use 
Table 3 is a quick access guide to CAM use over a 12-month period as reported from the 49 surveys conducted in 15 
countries. It shows the percentage of the general population using at least one type of CAM (all-CAM use),the 
percentage visiting any CAM practitioner (all CAM-visits), and gives an assessment of each survey using our quality 
criteria. Table 4 gives details for each survey of the survey population, the sampling and data collection method, the 
sample itself, and CAM use estimates with 95% CIs (CIs calculated by the review authors are identified). In both 
tables the survey data are grouped by age: adults or all ages; children; and older adults. Where possible, the following 
narrative identifies trends in CAM use by national populations from data obtained using consistent methodologies. 
 
USA 
Of the surveys (see Table 1) conducted in the USA from 1990 to 2007, five were government-sponsored surveys [24, 
31-34]. Data from the National Health Interview Surveys (NHIS) provided the best available evidence of recent trends 
in CAM use by adults (Tables 3 & 4). Excluding prayer, all-CAM use by adults (age 18+), over a 12-month period, was 
estimated to be 36% in 2002 [32] and 38% in 2007 [31]. Four US independent national surveys of adults (age 18+) 
conducted in the 1990s [3, 10, 35, 36] estimated rates for all-CAM use of 34 to 42%.Visits by adults to CAM 
practitioners in the USA (Tables 3 & 4) increased from 13% in 2002 to 16% in 2007 with substantial variation in the 
use of specific CAM therapies and reported significant increases in usage of some types of therapy including 
acupuncture and massage therapy [31, 32]. 
 
The data from the 2007 NHIS [31] indicates that all-CAM use in children (age 0-17) is considerably lower than for 
adults: 12% versus 38%. The Medical Expenditure Panel Survey (MEPS) of 1996 [28] also shows that adults (age 
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18+) were much more likely than children (age <18) to visit CAM practitioners (8% versus 2%). The three independent 
studies [37-39] of CAM use in later life (age 60+ or 65+) gave rates for all-CAM use varying from 41 to 63% (Table 3). 
 
UK 
In the UK, 12-month prevalence estimates for all-CAM use by adults in 1998 [40], 1999 [41] and 2005 [42] were 28%; 
20%; and 26% respectively. Fourteen percent of the adult population (age 18+) of England were reported to have 
visited at least one CAM practitioner in 1998 [40]. In 2001, the estimate for adults (age 16+) was 10% for England, 
Scotland and Wales [43], and 12% for England in 2005 [42]. None of these surveys used the same measurement tool.  
No UK estimates for children or older adults were identified. 
 
Canada 
The National Population Health Survey (NPHS) in Canada reported rates of adult (age 15+) visits to CAM practitioners 
at 15% in 1995 [44] and 17% (for age 18+) in 1999 [45]. Based on data from 2001-5 the Canadian Community Health 
Survey (CCHS) estimated that 12% of the population age 12 or older had visited some type CAM practitioner over a 
12-month period [46]. None of these three surveys estimated the 12-month prevalence of all CAM-use. 
 
Australia 
In Australia, the South Australian Health Omnibus Surveys (SAHOS) collected data on CAM use by adults (age 15+) 
living in Southern Australia in 1993, 2000 and 2004 [9, 29, 47]. These methodologically consistent studies report 
remarkably similar estimates of overall CAM-use during that period (49%, 52%, 52%). Visits to CAM practitioners were 
reported as 20% of the population in 1993 [9], 23% in 2000 [47] and 27% in 2004 [29]. As in the US, the SAHOS 2004 
survey showed lower rates of overall CAM use in children (age <15) than adults (18% versus 52%) [29, 30]. 
 
Other countries 
Data from survey reports in the remaining 11 countries were considered insufficient to indicate national trends in CAM 
use; surveys in Norway, Israel, Demark and Singapore used inconsistent measurement methods, targeted different 
populations, and/or the quality of the survey reports was assessed as poor. Of surveys with national samples, the 
three highest rates of CAM use were reported in East Asian countries: Japan: 76%, South Korea: 75%, and Malaysia: 
56% [48-50]. 
 
Discussion 
 
This is the most comprehensive and systematic review to date of surveys reporting the prevalence of CAM use by the 
general public. The two previous systematic reviews, published in 2000 [1, 2], together included 18 reports from 17 
surveys conducted in nine countries. Nine reports from the two previous reviews met the criteria for the current review, 
a further 40 surveys were identified yielding 42 further reports; 38 were published during or post-2000. The enduring 
popularity of CAM surveys was also evidenced by the number of repeat surveys conducted, particularly by 
government agencies, in the USA, Australia and the UK and the resultant data were used to explore trends in CAM 
use for this review. Reports of CAM surveys from many countries are absent and this partly reflects the limitation of 
excluding studies not written in English. 
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A total of 47 publications were reviewed containing 51 reports from 49 surveys conducted in 15 (out of a possible 196) 
countries. The surveys indicated that CAM was frequently used and that prevalence estimates varied widely between 
the 15 countries; the prevalence of all types of CAM use ranged from 9.8% to 76%, the range for visits to CAM 
practitioners was 1.8% to 48.7%. There was consistent evidence that adults were more frequent users of CAM than 
children; and that national estimates of CAM use were highest in East Asian countries such as Japan [48], South 
Korea [50], and Malaysia [49]. 
 
Prevalence estimates were also influenced by differences in methodology which make it difficult to compare figures 
between countries and within countries. Examples of this include variable age ranges and sampling techniques, but by 
far the most important source of variability which influences the comparability of estimates comes from the way in 
which CAM is defined and operationalised for data collection: of the 31 reports (61%) that used lists of named 
therapies to elicit CAM use, the number of therapies identified ranged from four to 36. Most surveys also allowed 
UHVSRQGHQWVWRUHSRUWWKHXVHRIµRWKHU¶W\SHVRI&$0, but CAM prevalence estimates were inflated by the inclusion of 
prayer as a type of CAM [32]. Use of prayer was most frequently reported in studies from the USA and East Asia. 
Other factors contributing to high estimates of CAM use were the inclusion of religious practices other than prayer 
[51]; named therapies not commonly regarded as CAM such as µdLHWDU\VXSSOHPHQWV¶[48]; and the use of indigenous, 
traditional medicine [52].  This reinforces the call for a more standardised approach to collecting comparable 
population data [13]. 
 
There was evidence of national trends in Australia, UK and USA. In Australia during 2004, about one in two adults and 
one in five children had used some type of CAM and about one in four adults had visited CAM practitioners [29, 30] 
with no significant change in CAM use from 2000 to 2004. UK surveys also suggested  that CAM use has remained 
fairly constant since 1998 [40] with about one in four adults using CAM and one in eight consulting a CAM practitioner 
during 2005 [42]. In the USA, CAM use has remained steady since 2002 with the most recent survey (2007) indicating 
that nearly four in ten adults and one in nine children had used some type of CAM [31]. However, in general, 
information on trends is limited by insufficient data from repeat surveys with consistent, high quality methods. 
 
There is currently no consensus regarding ³ZKDWLVTXDOLW\´LQWKHFRQWH[WRISUHYDOHQFHVXUYH\V6DQGHUVRQHWDO[19] 
argue for quality criteria focussed on the reduction of bias, but acknowledge that other aspects of quality are 
important. We aimed to produce quality criteria that relate to the likely robustness and interpretability of the estimates 
produced. The development of the assessment tool was based on researcher experience and authoritative sources. 
Our experience of applying the six identified criteria suggested they had face validity, but further work is needed to 
establish their reliability and validity. Reliable and valid criteria can be used to select high quality surveys for future 
systematic reviews and to help guide the development and reporting of prevalence surveys. 
 
Application of the six-item quality assessment tool developed for this review suggested that the quality was variable; 
thirty survey reports (59%) achieved four or more of the six quality criteria. There was no evidence an association 
between date of publication and quality, but we did observe a trend towards higher quality in the government-
sponsored surveys, according to our criteria. 
 
The rationales cited for conducting CAM surveys in the reports reviewed were predominantly concerned with 
perceptions of the popularity of CAM, and its increasing use, and the implications of this for public health and health 
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service planning. Recent surveys have revealed that delayed medical care was associated with CAM use in the USA 
[53]; that most respondents in Australia were unaware that CAM use was not routinely tested for safety and efficacy 
by a government agency [29]; and that more than one in four UK respondents taking prescribed drugs stated they 
were also using CAM [42]. All of the recent reports in Australia, UK, and USA [29, 31, 42] emphasised the need to 
improve communication between physicians and patients about their use of CAM; openness and non-judgemental 
communication is needed to determine the risks of drug interactions and other potential complications [29]. Periodic 
surveys of general populations are required to monitor changing patterns in CAM use as well as public perceptions 
and awareness, and the quality of communication between healthcare providers and their users. 
 
Finally, most studies reviewed also reported estimates for visits to specific CAM practitioners. This will be the subject 
of a separate publication and complete the picture of the world-wide use of CAM based on the best available 
evidence. 
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Appendix 1: Medline search strategy 
 
 
Search terms for complementary and alternative medicine (CAM) 
1 exp Complementary Therapies/ 
2 (complementary adj5 medicine$).tw. 
3 (complementary adj5 therap$).tw. 
4 (complementary adj5 health care).tw. 
5 (complementary adj5 healthcare).tw. 
6 (complementary adj5 treatment$).tw. 
7 alternative medicine$.tw. 
8 alternative therap$.tw. 
9 alternative health care.tw. 
10 alternative healthcare.tw. 
11 alternative treatment$.tw. 
12 (unconventional adj5 medicine$).tw. 
13 (unconventional adj5 therap$).tw. 
14 (unconventional adj5 care).tw. 
15 (unconventional adj5 health care).tw. 
16 (unconventional adj5 healthcare).tw. 
17 (unconventional adj5 treatment$).tw. 
18 (nonconventional adj5 medicine$).tw. 
19 (non-conventional adj5 medicine$).tw. 
20 (nonconventional adj5 health care$).tw. 
21 (non-conventional adj5 health care$).tw. 
22 (nonconventional adj5 healthcare$).tw. 
23 (non-conventional adj5 healthcare$).tw. 
 
Search terms for prevalence, surveys or patterns of use 
24 Prevalence/ 
25 prevalence.tw. 
26 Health Care Surveys/ 
27 survey$.tw. 
28 "pattern$ of use".tw. 
29 "pattern$ of usage".tw. 
30 "level$ of use".tw. 
31 "level$ of usage".tw. 
 
Combining terms for CAM and prevalence/surveys 
32 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 
or 18 or 19 or 20 or 21 or 22 or 23 
33 24 or 25 or 26 or 37 or 28 or 29 or 30 or 31 
34 32 and 33 
 
Terms for population-level or national-level data 
35 national.tw. 
36 population.tw. 
37 Population/ 
 
Combining terms 
38 35 or 36 or 37 
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39 34 and 38 
 
Restricting to 1998 onwards 
40 limit 39 to yr="1998 - current" 
($ = truncation; / = medical subject heading; tw = title/abstract free text search) 
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Box 1: Quality assessment criteria for reports of the 12-month population prevalence of CAM use  
 
Study design 1.  Measurement method± CAM-use questions clearly described and number of 
therapies/questions reported. 
2.  Piloting of survey reported (or assumed for government surveys). 
3.  6DPSOHVL]HDQGRU&$0-specific sample size calculation reported. 
Data collection 4. 5HSRUWHGVXUYH\UHVSRQVHUDWH 
Analysis 5. Data weighted to population characteristics (where appropriate) to reduce non-
response bias. 
Reporting 6. 95% confidence interval or standard error reported for main prevalence estimates. 
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Figure 1: PRISMA flow chart of included and excluded studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References identified through 
database searching: 
2303 
References identified through previous 
reviews and citation tracking: 
9 
Number of references (after 
removal of duplicates): 
2312 
References examined as 
full texts: 
104 
References excluded at title and 
abstract stage: 
2208 
References excluded at 
full text stage: 
57 
References included: 
47 
 
relating to: 49 surveys 
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Table 1: Quality assessment of survey reports of CAM use (NR = data not reported) 
 
Country 
(year of 
survey) 
First author 
(year of pub.) 
CAM-use measurement 
method (N)1 
Piloting of 
survey 
reported2 
Sample size 
and/or calculation 
reported (SSC) 
Reported response rate 
DGMXQDGM15 
Data weighted 
to population 
characteristics 
95% CI or 
SE reported 
Meets 4 
quality 
criteria 
USA 
(2007) 
Barnes (2008) 
[31] 
Named therapies (36) Gvt. 
Survey 
Age 18+: 23,393 
Age 0-17:9,417 
Age 18+: 67.8% (NR) 
Age 0-17: 76.5% (NR) 
Yes SE Yes 
USA 
(2002) 
Barnes (2004) 
[32] 
Named therapies (27) Gvt. 
Survey 
31,044  74.3% (adj) Yes SE Yes 
USA 
(2001) 
Hughes (2006) 
[54] 
Open questions (NR) Piloted 1,104 65.9% (NR) NR NR - 
USA 
(1999) 
Arcury (2004) [55] Open questions (NR) NR 1,059 83.8% (NR) Yes SE Yes 
USA 
(1999) 
Ni (2002) [33] Named therapies (12) Gvt. 
Survey 
30,801 70% (NR) Yes CI Yes 
USA 
(1998) 
Oldendick (2000) 
[56] 
Named therapies (NR) NR 1,584 66.2% (NR) Yes CI Yes 
USA 
(1997-8) 
Astin (2000) [37] Named therapies (10) NR 728 51% (unadj) NR NR - 
USA 
(1997) 
Eisenburg (1998) 
[3] 
Named therapies (16) Piloted 2,055; SSC 60% (adj); 49% (unadj) Yes SE Yes 
USA 
(1997) 
Landmark 
Healthcare (1998) 
[36] 
Named therapies(11) NR 1,500 NR NR CI - 
USA 
(1996) 
Druss (1999) [24] Named therapies (11) Gvt. 
Survey 
Age 18+: 16,068 77.7% (NR) Yes NR Yes 
Davis (2003) [28] Named therapies (11) Gvt. 
Survey 
Age <18: 6262 Children interviewed 
by proxy 
Yes CI Yes 
USA 
(1995-6) 
Honda (2005) [34] Named therapies (14) Gvt. 
Survey 
4,242 60.8% (NR) Yes NR Yes 
USA  
(1994) 
Paramore (1997) 
[57] 
Named therapies (4) NR 3,450 75% (NR) Yes NR Yes 
USA 
(1990) 
Eisenberg (1993) 
[35] 
Named therapies (16) Piloted 1,539; SSC 67% (unadj) Yes CI Yes 
USA  
(NR) 
Cheung (2007) 
[38] 
Named therapies (16) Piloted 445; SSC 37% (unadj) NR NR - 
USA 
(NR) 
Shreffler-Grant 
(2005) [39] 
Open questions(NR) Piloted 325 69.3% (unadj) NR NR - 
USA 
(NR) 
Astin (1998) [10] Named therapies (17) NR 1,035 69% (unadj) NR NR - 
UK 
(2005) 
Hunt (2010) [42] Named therapies (23) Gvt. 
Survey 
7,630 71% (unadj) NR NR Yes 
UK 
(2001) 
Thomas (2004) 
[43] 
Named therapies (23) Gvt. 
Survey 
1,794 65% (unadj) NR CI Yes 
UK 
(1999) 
Ernst (2000) [41] Open questions (5) NR 1,204 NR Yes NR - 
UK 
(1998) 
Thomas (2001) 
[40] 
Named therapies (10) Piloted 2,669; SSC 59% (adj) Yes CI Yes 
UK  
(1993) 
Thomas (1993) 
[14] 
Named therapies (6) Piloted 676 78% (adj) Yes CI Yes 
UK 
(1986) 
Yung (1988) [58] Named therapies (6) Gvt. 
Survey 
4,268 70% (adj) NR CI Yes 
Canada 
(2001-5) 
Metcalfe (2010) 
[46] 
Named therapies (14) Gvt. 
Survey 
400,055 NR Yes CI Yes 
Canada 
(1998-9) 
Millar (2001) [45] Open questions (2) Gvt. 
Survey 
14,150 NR Yes NR Yes 
Canada 
(1994-5) 
Millar (1997) [44] Open questions (2) Gvt. 
Survey 
17,626 NR Yes NR Yes 
Canada 
(1988) 
Northcott (1993a) 
[26] 
Named therapies (NR) Gvt. 
Survey 
464 80% (NR) NR NR - 
Canada 
(1979) 
Northcott (1993b) 
[26] 
Named therapies (NR) Gvt. 
Survey 
439 75% (NR) NR NR - 
Australia 
(2005) 
Xue (2007) [59] Named therapies (17) Piloted 1,067; SSC NR Yes CI Yes 
Australia 
(2004) 
MacLennan 
(2006) [29] 
Named therapies (16) Gvt. 
Survey 
Age 15+: 3,015 71.7% (unadj) Yes CI Yes 
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Country 
(year of 
survey) 
First author 
(year of pub.) 
CAM-use measurement 
method (N)1 
Piloting of 
survey 
reported2 
Sample size 
and/or calculation 
reported (SSC) 
Reported response rate 
DGMXQDGM15 
Data weighted 
to population 
characteristics 
95% CI or 
SE reported 
Meets 4 
quality 
criteria 
Smith (2006) [30] Named therapies (12) Gvt. 
Survey 
Age <15: 911 Children interviewed 
by proxy 
Yes CI Yes 
Australia 
(2000) 
MacLennan 
(2002) [47] 
Named therapies (NR) Gvt. 
Survey 
3,027 70.4% (NR) Yes CI Yes 
Australia 
(1993) 
MacLennan 
(1996) [9] 
Named therapies (19) Gvt. 
Survey 
3,004 73.6% (NR) Yes NR Yes 
Norway  
(2007) 
Fonnebo (2009) 
[60] 
Named therapies (8) NR 1,007 NR NR NR - 
Norway  
(2002) 
Steinsbekk (2009) 
[61] 
Open question(1) Gvt. 
Survey 
6,612 70.4% (NR) Yes NR Yes 
Norway 
(1997) 
Hanssen (2005a) 
[11] 
Open questions (5) NR 1,000 51% (unadj) NR NR - 
Norway 
(1995-7) 
Steinsbekk (2007) 
[62] 
Open question(1) NR 54,448 59% (unadj) NR NR - 
Israel 
(2003-4) 
Niskar (2007) [63] NR Gvt. 
Survey 
2,365 58.6% (unadj) NR NR - 
Israel 
(2000) 
Schmueli (2004a) 
[27] 
NR NR 2,505 NR NR NR - 
Israel 
(1993) 
Schmueli (2004b) 
[27] 
NR NR 2,003 NR NR NR - 
Denmark 
(2000) 
Hanssen (2005b) 
[11] 
Open questions (4) Gvt. 
Survey 
16,690 74% (unadj) NR NR Yes 
Denmark 
(1987) 
Rasmussen 
(1990) [64] 
NR Gvt. 
Survey 
4,753 NR NR NR - 
Singapor
e 
(2003-4) 
Feng (2010) [65]  Named therapies (NR) Gvt. 
Survey 
1,092 72.4% (NR) Yes NR Yes 
Singapor
e 
(2002) 
Lim (2005) [52] Open questions(NR) Piloted 468 72.2% (unadj) NR CI - 
Germany 
(1997-
2001) 
Schwarz (2008) 
[66] 
Named therapies (14) NR 4,291 68.8% (unadj) NR NR - 
Italy 
(1996-7) 
Dello Buono 
(2001) [67] 
Open questions(NR) NR 655 65 % (adj); 58% 
(unadj) 
NR NR - 
Japan 
(2001) 
Yamashita (2002) 
[48] 
Named therapies (10) Piloted 1,000 NR Yes CI Yes 
Malaysia 
(2004) 
Siti (2009) [49] Open questions (4) Gvt. 
Survey 
6,947 81% (adj) Yes CI Yes 
Saudi 
Arabia 
(2003) 
Al-Faris (2008) 
[51] 
NR Piloted 1,408; SSC 95% (unadj) NR CI Yes 
South 
Korea 
(2006) 
Ock (2009) [50] Named therapies (27) NR 3,000 49.8% (unadj) Yes NR - 
Sweden 
(2000) 
Hanssen (2005c) 
[11] 
Open questions (4) NR 1,001 63% (unadj) NR NR - 
1
 3DUHQWKHVLVIROORZLQJµ1DPHGWKHUDSLHV¶LQFOXGHVQXPEHURIWKHUDSLVWVWKHUDSLHVDQGRYHU-the -counter products named in the survey (excludes 
µRWKHU¶FDWHJRU\IROORZLQJµ2SHQTXHVWLRQVSDUHQWKesis includes number of interview questions. 
2
 Piloting was assumed for government surveys. 
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Table 2: Summary of the quality of survey reports 
 
 
 
Quality criterion 
All survey 
reports 
N = 51 
Gvt. sponsored 
survey reports 
N = 24 
Other CAM 
survey reports 
N = 27 
n % n % n % 
1. CAM-use 
measurement method 
clearly described 
36 71 18 75 18 67 
2. Piloting of survey 
reported (or assumed for 
government surveys) 
35 69 24 100 
(assumed) 
11 41 
3. Sample size 1,000 
and/or sample size 
calculation reported 
43 84 21 88 22 82 
4. Reported survey 
response rate 60% 
31 61 17 71 14 52 
5. Data weighted to 
population characteristics 
27 53 16 67 11* 41 
6. 95% confidence 
interval or standard error 
reported for main 
prevalence estimates 
22 43 11 46 11 41 
Four or more criteria 
met 
30 59 20 83** 10 37 
*Inc. one survey (Al-Faris et al 2008) with 95% response reported where this was deemed unnecessary. 
**This includes the assumption that the pilot criterion is 100% for this group. 
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Table 3: Summary of CAM use in 15 countries: all-CAM use and all CAM-visits to practitioners 
 
Country Age group Survey type Sample size 
(range) 
All-CAM use % 
(year of survey) 
All CAM ±visits % 
(year of survey) 
Refs, name of 
survey1 
Meets 
quality 
criteria 
Adult or all 
ages 
       
USA Adult or all 
ages 
Government 
national 
4,242 ± 
31,044 
2007: 38.3 
2002: 36.0 
1999: 28.9 
 
1995-6: 54.0 
2007: 16.2 
2002: 12.5 
 
1996: 8.3 
[31] NHIS 
[32] NHIS 
[33] NHIS 
[24] MEPS 
[34] MIDUS 
Yes 
Yes 
Yes 
Yes 
Yes 
USA Adult or all 
ages 
Other national 1,035 ± 3,450 1997: 42.1, 
42.0 
 
1990: 33.8 
NR: 40.0 
1997: 19.5 
1994: 9.4 
1990: 12.3 
[3, 36] 
[57] 
[35] 
[10] 
Yes, No 
Yes 
Yes 
- 
USA Adult or all 
ages 
Sub-national 1,059 - 1,584 1999: 45.7 
1998: 43.7 
1999: 8.6 [55] 
[56] 
Yes 
Yes 
UK Adult or all 
ages 
Government 
national 
1,794 - 7,630 2005: 26.3 2005: 12.1 
2001: 10.0 
[42] HSE 
[43] NOS 
Yes 
Yes 
UK Adult or all 
ages 
Other national 676 - 2,669 1999: 20.3 
1998: 28.3 
 
1998: 13.6 
1993: 8.5 
[41] 
[40] 
[14] 
No 
Yes 
Yes 
UK Adult or all 
ages 
Government 
sub-national 
4,268  1986: 2.6 [58] CHS Yes 
Canada Adult or all 
ages 
Government 
national 
14,150 - 
400,055 
 2001-5: 12.4 
1998-9: 17.0 
1994-5: 15.0 
[46] CCHS 
[45] NPHS 
[44] NPHS 
Yes 
Yes 
Yes 
Canada Adult or all 
ages 
Government 
sub-national 
439 - 464 1988: 14.4 
1979: 9.8 
 [26] AEAS 
[26] AEAS 
No 
No 
Australia Adult or all 
ages 
Other national 1,067 2005: 68.9 2005: 44.1 [59] Yes 
Australia Adult or all 
ages 
Government 
sub-national 
3,004 ± 3,027 2004: 52.2 
2000: 52.1 
1993: 48.5 
2004: 26.5 
2000: 23.3 
1993: 20.3 
[29] SAHOS 
[47] SAHOS 
[9] SAHOS 
Yes 
Yes 
Yes 
Norway Adult or all 
ages 
Government 
national 
6,612  2002: 8.7 [61] LLS Yes 
Norway Adult or all 
ages 
Other national 1,000 - 1,007  2007: 48.7 
1997: 12.0 
[60] 
[11] 
No 
No 
Norway Adult or all 
ages 
Sub-national 54,448  1995-7: 9.9 [62] No 
Israel Adult or all 
ages 
Government 
national 
2,365  2003-4: 5.8 [63] INHIS No 
Israel Adult or all 
ages 
Sub-national 2,003 - 2,505  2000: 9.8 
1993: 6.1 
[27] 
[27] 
No 
No 
Denmark Adult or all 
ages 
Government 
national 
4,753 - 
16,690 
 2000: 21.0 
1987: 10.0 
[11] SUSY 
[64] DICE 
Yes 
No 
Singapore Adult or all 
ages 
Sub-national 468 2002: 76.0  [52] No 
Germany Adult or all 
ages 
Sub-national 4,291  1997-2001: 6.0 [66] No 
Japan Adult or all 
ages 
Other national 1,000 2001: 76.0  [48] Yes 
Malaysia Adult or all 
ages 
Government 
national 
6,947 2004: 55.6  [49] Yes 
Saudi Arabia Adult or all 
ages 
Sub-national 1,408 2003: 67.8 2003: 23.9 [51] Yes 
South Korea Adult or all 
ages 
Other national 3,000 2006: 74.8  [50] No 
Sweden Adult or all 
ages 
Sub-national 1,001 2000: 20.0  [11] No 
Children        
USA Children Government 
national 
6,262 - 9,417 2007: 11.8  
1996: 1.8 
[31] NHIS 
[28] MEPS 
Yes 
Yes 
USA Children Sub-national 1,104  2001: 22.6 [54] No 
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Country Age group Survey type Sample size 
(range) 
All-CAM use % 
(year of survey) 
All CAM ±visits % 
(year of survey) 
Refs, name of 
survey1 
Meets 
quality 
criteria 
Australia Children Government 
sub-national 
911 2004: 18.4  [30] SAHOS Yes 
Older adults        
USA Older adults Sub-national 325 - 728 1997-8: 41.0 
NR: 45.2, 
62.9 
 
NR: 17.5 
[37] 
[38, 39] 
No 
No, No 
Singapore Older adults Government 
national 
1,092 2003-4: 44.6  [65] NMHSE Yes 
Italy Older adults Sub-national 655 1996-7: 29.5  [67] No 
1Survey names are provided where reported for government surveys: AEAS = Annual Edmonton Area Survey; CCHS = Canadian Community 
Health Survey; CHS = Cardiff Health Survey; DICE = Danish Institute for Clinical Epidemiology; HSE = Health Survey for England; INHIS = Israeli 
National Heath Interview Survey; LLS = Level of Living Survey; MEPS = Medical Expenditure Panel Survey; MIDUS = Midlife Development in the 
US; NHIS = National Health Interview Survey; NOS = National Omnibus Survey; NMHSE = National Mental Health Survey of the Elderly; NPHS = 
National Population Health Survey; SAHOS = South Australian Health Omnibus Survey; (SUSY = abbreviation not reported). 
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Table 4: Detail of CAM use in 15 countries: all-CAM use and all CAM-visits to practitioners 
 
Country 
(year of 
survey) 
First author 
(year of pub.) 
Population (name of Gvt. 
Survey) 
Sampling method Data collection 
method 
Includes 
prayer 
N Sample 
ages 
(% males) 
All CAM 
use % 
 
All-CAM use 
95% CI 
All CAM 
visits % 
All CAM-
visits 
95% CI 
Meets >= 
4 quality 
criteria 
Adult or all ages 
USA 
(2007) 
Barnes (2008) 
[31] 
National 
(National Health Interview 
Survey, NHIS) 
Random sample of households Interview No1 23,393 
(18+) 
18+ (NR) 38.3 37.7-38.9* 16.2 15.7-16.7* Yes 
USA 
(2002) 
Barnes (2004) 
[32] 
National (National Health 
Interview Survey, NHIS) 
Random sample of households Interview Yes 
No 
31,044 18+ (NR) 62 
36.0 
61.6-62.6* 
35.5-36.5* 
 
12.5 
12.1-12.9* Yes 
USA 
(1999) 
Arcury (2004) 
[55] 
Sub-national 
(NA) 
Stratified cluster sample Interview No 1,059 18+ (NR) 45.7 42.7-48.7* 8.6 6.9-10.3* - 
USA 
(1999) 
Ni (2002) [33] National (National Health 
Interview Survey, NHIS) 
Nationally representative sample  Interview Yes 30,801 18+ (NR) 28.9 28.1-29.7 - - Yes 
USA 
(1998) 
Oldendick (2000) 
[56] 
Sub-national 
(NA) 
Random digit dialling Telephone interview No 1,584 18+ (38) 43.7 41.2-46.2 - - Yes 
USA 
(1997) 
Eisenburg (1998) 
[3] 
National (NA) Random sample of household 
telephones 
Telephone interview  No 2,055 18+ (48) 42.1 40.0-44.2* 19.5 17.8-21.2* Yes 
USA 
(1997) 
Landmark 
Healthcare 
(1998) [36] 
National 
(NA) 
Random sample of households Telephone interview No 1,500 18+ (NR) 42.0 39.5-44.5 - - - 
USA 
(1996) 
Druss (1999) [24] National 
(Medical Expenditure Panel 
Survey, MEPS) 
Random sample of population Interview No 16,068 18+ (47) - - 8.3 7.9-8.7* Yes 
USA 
(1995-6) 
Honda (2005) 
[34] 
National (Midlife 
Development in the US, 
MIDUS) 
Nationally representative sample Telephone interview 
+ postal 
questionnaire 
Yes 4,242  25-74 (43) 54.0 52.5-55.5* - - Yes 
USA  
(1994) 
Paramore (1997) 
[57] 
National (NA) Nationally representative sample Interview No 3,450 All ages incl. 
children (NR) 
- - 9.4 8.4-10.4* Yes 
USA 
(1990) 
Eisenberg (1993) 
[35] 
National (NA) Random sample of household 
telephones 
Telephone interview No 1,539 18+ (52) 33.8 31.0-37.0 12.3 10.7-13.9* Yes 
USA 
(NR) 
Astin (1998) [10] National 
(NA) 
Random sample of self-selecting 
group 
Postal questionnaire No 1,035 18+ (49) 40.0 37.0-43.0* - - - 
UK 
(2005) 
Hunt (2010) [42] National (Health Survey for 
England, HSE) 
Random sample of households Interview No 7,630 16+ (45) 26.3 25.3-27.3* 12.1 11.4-12.8* Yes 
UK 
(2001) 
Thomas (2004) 
[43] 
National (National Omnibus 
Survey, NOS) 
Random sample within postal 
sectors 
Interview No 1,794 16+ (47) - - 10.0 8.7-11.5 Yes 
UK 
(1999) 
Ernst (2000) [41] National (NA) Random-digit dialling Telephone interview No 1,204 18+ (45) 20.3 18.0-22.6* - - - 
UK 
(1998) 
Thomas (2001) 
[40] 
National (NA) Random sample of 12 health 
authorities 
Postal questionnaire No 2,669 18+ (43) 28.3 26.6-30-0 13.6 12.3-14.9 Yes 
UK  
(1993) 
Thomas (1993) 
[14] 
National (NA) Random sample from electoral 
register 
Postal questionnaire No 676 18+ (47) - - 8.5 6.7-10.9 Yes 
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UK 
(1986) 
Yung (1988) [58] Sub-national (Cardiff Health 
Survey, CHS) 
Random sample from electoral 
register 
Postal questionnaire No 4,268 18+ (NR) - - 2.6 2.2-3.0 Yes 
Canada 
(2001-5) 
Metcalfe (2010) 
[46] 
National (Canadian 
Community Health Survey, 
CCHS) 
Random cluster sample of 
households 
Interview No 400,055 12+ (49) - - 12.4 12.2-12.5 Yes 
Canada 
(1998-9) 
Millar (2001) [45] National (National 
Population Health Survey, 
NPHS) 
Longitudinal sample from 
randomly selected participants in 
1994-5 survey 
Telephone interview No 14,150 18+ (46) - - 17.0 16.4-17.6* Yes 
Canada 
(1994-5) 
Millar (1997) [44] National (National 
Population Health Survey, 
NPHS) 
Random sample of households Interview No 17,626 15+ (NR) - - 15.0 14.5-15.5* Yes 
Canada 
(1988) 
Northcott (1993a) 
[26] 
Sub-national (Annual 
Edmonton Area Survey, 
AEAS) 
Representative sample derived 
from census data. 
Interview No 464 18+ (49) 14.4  11.2-17.6* - - - 
Canada 
(1979) 
Northcott (1993b) 
[26] 
Sub-national (Annual 
Edmonton Area Survey, 
AEAS) 
Representative sample derived 
from census data. 
Interview No 439 18+ (47) 9.8 7.0-12.6* - - - 
Australia 
(2005) 
Xue (2007) [59] National (NA) Random-digit dialling with quota 
for age and sex 
Telephone interview No 1,067 18+ (49) 68.9 66.1-71.7 44.1 41.1-47.1 Yes 
Australia 
(2004) 
MacLennan 
(2006) [29] 
Sub-national (South 
Australian Health Omnibus 
Survey, SAHOS) 
Random cluster sample of 
households 
Interview No 3,015 15+ (49) 52.2 50.3-54.1 26.5 24.9-28.1* Yes 
Australia 
(2000) 
MacLennan 
(2002) [47] 
Sub-national (South 
Australian Health Omnibus 
Survey, SAHOS) 
Random cluster sample of 
households 
Interview No 3,027 15+ (49) 52.1 50.3-53.9 23.3 22.1-24.5 Yes 
Australia 
(1993) 
MacLennan 
(1996) [9] 
Sub-national (South 
Australian Health Omnibus 
Survey, SAHOS) 
Random cluster sample of 
households 
Interview No 3,004 15+ (49) 48.5 46.7-50.3* 20.3 18.9-21.7* Yes 
Norway  
(2007) 
Fonnebo (2009) 
[60] 
National (NA) Random sample of telephone 
users (landlines stratified by 
location) 
Telephone interview No 1,007 15+ (46) - - 48.7 45.6-51.8* - 
Norway  
(2002) 
Steinsbekk 
(2009) [61] 
National (Level of Living 
Survey, LLS) 
Nationally representative sample 
of households 
NR No 6,612 18+ (44) - - 8.7 8.0-9.4* Yes 
Norway 
(1997) 
Hanssen (2005a) 
[11] 
National (NA) Nationally representative sample  Telephone interview No 1,000 NR (44) - - 12.0 10.0-14.0* - 
Norway 
(1995-7) 
Steinsbekk 
(2007) [62] 
Sub-national (NA) NR Postal questionnaire No 54,448 20+ (45) - - 9.9 9.6-10.2* - 
Israel 
(2003-4) 
Niskar (2007) [63] National (Israeli National 
Heath Interview Survey, 
INHIS) 
Random sample of general 
population 
Telephone interview No 2,365 21+ (44) - - 5.8 4.9-6.7* - 
Israel 
(2000) 
Schmueli (2004a) 
[27] 
Sub-national (NA) NR Interview No 2,505 45-75 (47.4) - - 9.8 8.6-11.0* - 
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Israel 
(1993) 
Schmueli (2004b) 
[27] 
Sub-national (NA) NR Interview No 2,003 45-75 (47.5) - - 6.1 5.1-7.1* - 
Denmark 
(2000) 
Hanssen (2005b) 
[11] 
National (SUSY-2000) Nationally representative sample Interview No 16,690 16+ (49) - - 21.0 20.4-21.6* Yes 
Denmark 
(1987) 
Rasmussen 
(1990) [64] 
National (Danish Institute for 
Clinical Epidemiology, 
DICE) 
NR Interview No 4,753 16+ (NR) - - 10.0 9.1-10.9* - 
Germany 
(1997-
2001) 
Schwarz (2008) 
[66] 
Sub-national (NA) A two-stage cluster sample Interview No 4,291 20-79 (49) - - 6.0 5.3-6.7* - 
Japan 
(2001) 
Yamashita (2002) 
[48] 
National (NA) Random-digit dialling with 
stratified sample 
Telephone interview No 1,000 20-79 (49) 76.0 73.4-78.6 - - Yes 
Malaysia 
(2004) 
Siti (2009) [49] National (by Ministry of 
Health, Malaysia) 
Stratified random sampling (by 
age, gender, and ethnicity) 
Interview Yes 6,947 0-80+ (NR) 55.6 53.8-57.4 - - Yes 
Saudi 
Arabia 
(2003) 
Al-Faris (2008) 
[51] 
Sub-national (NA) Random cluster sample of 
households 
Interview Yes 1,408 M 35.5; SD 
13.9 (39) 
67.8 66-70 23.9 21.7-26.1* Yes 
Singapore 
(2002) 
Lim (2005) [52] Sub-national (NA) Random sample of housing 
estate (demographically 
matching Singapore) 
Interview No 468 18+ (46) 76.0 73.9-77.9 - - - 
South 
Korea 
(2006) 
Ock (2009) [50] National (NA) Proportionate quote sampling (by 
area, age, and gender) 
Interview Yes 3,000 30-69 (50) 74.8 73.2-76.4* - - - 
Sweden 
(2000) 
Hanssen (2005c) 
[11] 
Sub-national (NA) NR Telephone interview No 1,001 16-84 (47) 20.0 17.5-22.5* - - - 
Children 
USA 
(2007) 
Barnes (2008) 
[31] 
National 
(National Health Interview 
Survey, NHIS) 
Random sample of households Interview by proxy No 9,417 (0-
17) 
0-17 (NR) 11.8 11.1-12.5* - - Yes 
USA 
(2001) 
Hughes (2006) 
[54] 
Sub-national 
(NA) 
Representative sample of 
households 
Telephone interview 
by proxy 
No 1,104 0-18 (52) - - 22.6 20.1-25.1* - 
USA 
(1996) 
Davis (2003) [28] National 
(Medical Expenditure Panel 
Survey, MEPS) 
Random sample of population Interview by proxy Yes 6262 <18 (52) - - 1.8 1.3-2.3 Yes 
Australia 
(2004) 
Smith (2006) [30] Sub-national (South 
Australian Health Omnibus 
Survey, SAHOS) 
Random cluster sample of 
households 
Interview by proxy No 911 15  (46) 18.4 15.9-21.0 - - Yes 
Older adults 
USA 
(1997-8) 
Astin (2000) [37] Sub-national 
(NA) 
NR Postal questionnaire No 728 65+ (45) 41.0 37.4-44.6* - - - 
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USA  
(NR) 
Cheung (2007) 
[38] 
Sub-national (NA) Randomly selected from drivers 
license & ID database of over 
65s 
Postal questionnaire Yes 445 65-94 (45) 62.9 58.4-67.4* - - - 
USA 
(NR) 
Shreffler-Grant 
(2005) [39] 
Sub-national (NA) Random sample rural 
communities 
Telephone interview No 325 60+ (51) 45.2 39.8-50.6* 17.5 13.4-21.6* - 
Italy 
(1996-7) 
Dello Buono 
(2001) [67] 
Sub-national (NA) Random sample from electoral 
register 
Interview No 655 65+ (37) 29.5 26.0-33.0* - -  
Singapore 
(2003-4) 
Feng (2010) [65] National (National Mental 
Health Survey of the Elderly, 
NMHSE) 
Random sample of households Interview No 1,092 60+ (44) 44.6 41.7-47.5* - -  
*95% CI calculated by review authors using the formula: 95% CI = proportion (p) +/- 1¥>S-p) / N]. 
1. Su & Li 2011 [53] cited all-CAM use for 18+: with prayer 60.1%; without prayer 29.4% (slightly different Ns). 
